| 2017-05-19 07:02:14 | athenahealth price target raised to $154 from $119 at OppenheimerOppenheimer analyst Mohan Naidu raised his price target for athenahealth to $154 after hosting investor meetings with management. The analyst hopes the presence of Elliott Management "doesn't drastically change the focus on creating the disruptive next-generation healthcare platform for near-term gain." He notes that management expressed confidence in their new guidance. Naidu keeps an Outperform rating on athenahealth. | |
|---|---|---|
| ||
| | |
| | |
| ||
| | |
| , |
| |
| , |
| |
|---|---|---|
| ||
| | |
| , … |
| |
| , |
|
| | |
| , … |
| |
| | |
| | |
|
| | |
| | |
| , |
| |
| ||
|
| ||
| | |
| ||
| ||
|